Following the US approval of the Agent paclitaxel-coated balloon for the treatment of in-stent restenosis (ISR), the first coronary procedures with the device were performed Tuesday morning at two ...
The algorithm can identify noncoronary signals, offering insights into ventricular function and cardiac index, investigators say.
With further validation, the technology could help “democratize” knowledge to benefit a broad swath of operators.